Glenmede Trust’s Cytosorbents Corp CTSO Stock Holding History

Glenmede Trust’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-111	Closed	-$17K	–	1455
2020 Q3	$17K	Buy	111 +3	+3%	+$541	﹤0.01%	1671
2020 Q2	$20K	Hold	108	–	–	﹤0.01%	1592
2020 Q1	$8K	Hold	108	–	–	﹤0.01%	2509
2019 Q4	$8K	Hold	108	–	–	﹤0.01%	2509
2019 Q3	$10K	Hold	108	–	–	﹤0.01%	2340
2019 Q2	$14K	Hold	108	–	–	﹤0.01%	2218
2019 Q1	$16K	Hold	108	–	–	﹤0.01%	2171
2018 Q4	$16K	Buy	+108	New	+$21.4K	﹤0.01%	2082
2018 Q3	–	Sell	-433	Closed	-$98K	–	1525
2018 Q2	$98K	Buy	+433	New	+$82K	﹤0.01%	1264
2017 Q4	–	Sell	-950	Closed	-$117K	–	2690
2017 Q3	$117K	Hold	950	–	–	﹤0.01%	1382
2017 Q2	$84K	Hold	950	–	–	﹤0.01%	1431
2017 Q1	$84K	Hold	950	–	–	﹤0.01%	1431
2016 Q4	$102K	Hold	950	–	–	﹤0.01%	1397
2016 Q3	$121K	Hold	950	–	–	﹤0.01%	1346
2016 Q2	$85K	Hold	950	–	–	﹤0.01%	1395
2016 Q1	$73K	Hold	950	–	–	﹤0.01%	1406
2015 Q4	$105K	Sell	950 -432	-31%	-$58.8K	﹤0.01%	1345
2015 Q3	$173K	Hold	1,382	–	–	﹤0.01%	1213
2015 Q2	$169K	Hold	1,382	–	–	﹤0.01%	1274
2015 Q1	$364K	Hold	1,382	–	–	﹤0.01%	1088
2014 Q4	$274K	Buy	+1,382	New	+$271K	﹤0.01%	1168

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's CTSO Position: Q4 2020 in Review

Glenmede Trust sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 111 shares — an estimated $17K sold.

Glenmede Trust first reported a position in CTSO in Q4 2014 and held it in 21 quarters. The position peaked at $364K in Q1 2015. 93 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

Glenmede Trust reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 111 Cytosorbents Corp shares in Q4 2020, an estimated $17K.
Glenmede Trust first reported a position in Cytosorbents Corp in Q4 2014 and held it in 21 quarters.
Glenmede Trust's Cytosorbents Corp position peaked at $364K in Q1 2015.
93 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.